 MONMOUTH JUNCTION, N.J., April 27, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4:45PM EST. 